ALS (CP4) Stock Price & Analysis
CP4 Stock Chart & Stats
- Day’s Range
- EUR 12.70 - EUR 13.00
- 52-Week Range
- EUR 11.30 - EUR 15.30
- Previous Close
- EUR 12.70
- Volume
- 0
- Average Volume (3M)
- 3
- Market Cap
- EUR 6.67B
- Enterprise Value
- EUR 12.02B
- Total Cash (Recent Filing)
- EUR 149.70M
- Total Debt (Recent Filing)
- EUR 1.57B
- Price to Earnings (P/E)
- 33.2
- Beta
- 0.81
- Next Earnings
- Nov 23, 2026 (Est.)
- EPS Estimate
- 0.26
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.98%
Bulls Say, Bears Say
Bulls Say
Consistent Revenue Growth
Multi-year revenue growth indicates continued demand for ALS’s testing and analytical services across resource, environmental, pharmaceutical, and commercial markets. This expanding base supports operating scale, provides a foundation for investment, and strengthens the durability of future earnings.
Resilient Operating Margins
Improving EBIT margins and consistently strong EBITDA margins show that ALS has maintained attractive operating economics as revenue expanded. Durable profitability can support reinvestment, absorb normal cost pressures, and convert market position into sustained operating cash generation.
Positive Cash Generation
The long-term increase in operating cash flow demonstrates that ALS’s services generate meaningful internal funding, rather than relying solely on external capital. Positive and improving cash generation supports debt reduction, business investment, and greater flexibility in capital allocation.
Bears Say
Earnings Volatility
The sharp net-margin contraction followed by a substantial rebound shows that earnings have been uneven below the operating line. Such volatility reduces confidence in the predictability of reported profits and can make future returns more sensitive to non-operating costs or one-off effects.
Inconsistent Cash Conversion
Although ALS generates positive cash, the weaker 2026 conversion of earnings into free cash flow indicates that accounting profits are not consistently translating into discretionary funds. This can constrain the pace of debt reduction, investment, and shareholder distributions if the pattern persists.
Recent Leverage Risk
The improvement in leverage is constructive, but the recent period of elevated debt-to-equity shows that ALS has carried meaningful balance-sheet risk. Higher leverage can reduce resilience during weaker profitability and limit financial flexibility until the lower debt position is sustained.
ALS News
CP4 FAQ
What was ALS’s price range in the past 12 months?
What is ALS’s market cap?
When is ALS’s upcoming earnings report date?
How were ALS’s earnings last quarter?
Is ALS overvalued?
Does ALS pay dividends?
What is ALS’s EPS estimate?
How many shares outstanding does ALS have?
What happened to ALS’s price movement after its last earnings report?
Which hedge fund is a major shareholder of ALS?
What is the TipRanks Smart Score and how is it calculated?
ALS Stock Smart Score
Company Description
ALS
ALS Limited delivers expert technical services globally, specializing in analytical testing, precise measurement, and comprehensive inspection across various sectors. Its operations span continents, encompassing Africa, Asia-Pacific, Europe, the Middle East, North Africa, and the Americas. The organization structures its operations into three core divisions: Life Sciences, Commodities, and Industrial. The Commodities division supports mining and mineral exploration firms by providing a comprehensive suite of services, including assaying, analytical testing, and metallurgy. These offerings cover geochemistry, metallurgy, inspection, and ensuring coal quality standards. Throughout the entire resource lifecycle, from initial exploration and feasibility studies to optimization, production, design, development, trade, and rehabilitation, this segment offers critical testing and advisory solutions. Furthermore, it handles coal sampling, analysis, certification, and evaluations of geological formations, alongside other associated analytical tests. The Life Sciences division focuses on the environmental, food, pharmaceutical, and consumer product sectors, delivering analytical testing, sampling, and remote monitoring. It conducts microbiological, physical, and chemical analyses. Moreover, this segment furnishes crucial analytical data to support consulting and engineering companies, various industries, and governmental bodies. The Industrial segment provides specialized diagnostic testing and engineering solutions tailored for the energy, resources, transportation, and infrastructure industries. It caters to a broad clientele, including asset owners, operational managers, construction firms, and equipment manufacturers across sectors such as power generation, petrochemicals, mining, mineral processing, water management, infrastructure development, and transportation. Established in 1863, the company, originally known as Campbell Brothers Limited, adopted its current name, ALS Limited, in August 2012. Its global operations are directed from its headquarters in Milton, Australia.
- Sector
- Industrials
- Industry
- Consulting Services
- CEO
- Malcolm Deane
- Employees
- 23,342
- Website
- www.alsglobal.com
- Address
- 25 King Street, Brisbane, QLD, 4006, AU
ALS (CP4) Earnings & Revenues
CP4 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 2 | 9 |
| Technical Analysis | 4 | 2 | 4 |
| Moving Averages | 7 | 0 | 5 |
